GSA Capital Partners »

Esperion Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.4M 1.1M 2.99
2023-09-30 $1.1M 1.1M 0.98
2023-06-30 $599k 431k 1.39
2023-03-31 $179k 113k 1.59
2022-12-31 $113k 18k 6.20
2021-09-30 $285k 24k 12.06
2020-12-31 $522k 20k 25.98
2020-09-30 $485k 13k 37.16
2019-06-30 $707k 15k 46.52
2017-09-30 $454k 9.1k 50.17
2017-06-30 $449k 9.7k 46.26
2017-03-31 $1.3M 36k 35.32
2015-09-30 $752k 32k 23.58
2015-06-30 $711k 8.7k 81.72